level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
Hire Dr. Balaji G.
United States

Ph.D. Chem | Organic chem | Small-molecule drug-discovery | Antimicrobial biopolymers | Polymer Synthesis

Profile Summary
Subject Matter Expertise
Services
Writing Clinical Trial Documentation, Medical Writing, Non-Medical Regulatory Writing, Technical Writing, Business & Legal Writing, Copywriting, Creative Writing, Newswriting, Audio Transcription
Research Fact Checking, Gap Analysis, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review
Consulting Scientific and Technical Consulting
Data & AI Data Visualization, Data Cleaning, Data Processing, Data Insights
Product Development Formulation, Recipe Development, Stability/Shelf Life Testing, Product Evaluation, Quality Assurance & Control (QA/QC), Prototyping, Reverse Engineering
Work Experience

PhD research scholar

PhD Researcher

September 2016 - May 2023

Education

PhD (Chemistry)

Pondicherry University

2016 - Present

PhD Chemistry

Pondicherry University

September 2016 - May 2023

Integrated Master of Science (Chemistry)

University of Hyderabad

2009 - 2014

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Balaji Gowrivel Vijayakumar and Deepthi Ramesh and Santhosh Manikandan Kumaravel and Mary Theresa and Aiswarya Sethumadhavan and Brindha Priyadarisini Venkatesan and E. K. Radhakrishnan and Maheswaran Mani and Tharanikkarasu Kannan(2022). Chitosan with pendant (E)-5-((4-acetylphenyl) diazenyl)-6-aminouracil groups as synergetic antimicrobial agents . Journal of Materials Chemistry B. Royal Society of Chemistry ({RSC})
Balaji Gowrivel Vijayakumar, Deepthi Ramesh, K. Santhosh Manikandan, Mary Theresa, Aiswarya Sethumadhavan, V. Brindha Priyadarisini, E. K. Radhakrishnan, Maheswaran Mani, Tharanikkarasu Kannan(2022). Chitosan with pendant (E)-5-((4-acetylphenyl)diazenyl)-6-aminouracil groups as synergetic antimicrobial agents . Journal of Materials Chemistry B. Royal Society of Chemistry ({RSC})
Lakshmi Haritha Bharathi Maganti, Deepthi Ramesh, Balaji Gowrivel Vijayakumar, Mohd Imran K. Khan, Arunkumar Dhayalan, Jayabal Kamalraja, Tharanikkarasu Kannan(2022). Acetylene containing 2-(2-hydrazinyl)thiazole derivatives: design, synthesis, and in vitro and in silico evaluation of antimycobacterial activity against Mycobacterium tuberculosis . RSC Advances. 12. (14). p. 8771--8782. Royal Society of Chemistry ({RSC})
Deepthi Ramesh, Amaresh Kumar Mohanty, Anirban De, Balaji Gowrivel Vijayakumar, Aiswarya Sethumadhavan, Suresh Kumar Muthuvel, Maheswaran Mani, Tharanikkarasu Kannan (2022). Uracil derivatives as HIV-1 capsid protein inhibitors: design, in silico, in vitro and cytotoxicity studies . RSC Advances.
Deepthi Ramesh, Balaji Gowrivel Vijayakumar, Tharanikkarasu Kannan(2020). Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders . European Journal of Medicinal Chemistry. 207. p. 112801. Elsevier {BV}
Ramesh, D., Joji, A., Vijayakumar, B.G., Sethumadhavan, A., Mani, M., Kannan, T.(2020). Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis . European Journal of Medicinal Chemistry. 198.
Vijayakumar, B.G., Ramesh, D., Joji, A., Jayachandra prakasan, J., Kannan, T.(2020). In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2 . European Journal of Pharmacology. 886.
BOOK CHAPTER
Deepthi Ramesh and Balaji Gowrivel Vijayakumar and Tharanikkarasu Kannan(2021). Therapeutic Targets for Emerging Zika Virus Infection and Vaccines in Clinical Trials . Frontiers in Clinical Drug Research: Anti-Infectives. p. 260--299. {BENTHAM} {SCIENCE} {PUBLISHERS}